Kelli Lehto - Epidemiology

Author Information

Kelli Lehto is a researcher affiliated with both the Department of Medical Epidemiology and Biostatistics at Karolinska Institutet in Stockholm, Sweden, and the Department of Chronic Diseases at the National Institute for Health Development in Tallinn, Estonia. Her work primarily focuses on the intersection of genetic risk factors and various health outcomes, with a significant emphasis on epidemiological studies related to mental health and age-related diseases.

Research Contributions

Kelli Lehto has made substantial contributions to the field of epidemiology, particularly in understanding the genetic underpinnings of health conditions such as ADHD and their broader implications on somatic and mental health. Her research also explores the comorbidity of atopic diseases and gastroesophageal reflux, suggesting shared etiological pathways. Additionally, she has been involved in international efforts to study the impact of COVID-19 on mental health across multiple nations, contributing to the development of cohort profiles and methodologies in this area.

Aliases

Kelli Lehto is also known in academic circles by the name K. Lehto. These aliases are used interchangeably in her publications and research contributions.

Publication and Citation Metrics

Publication Count	49
Citation Count	268
H-index	10

Publications:

The role of ADHD genetic risk in mid-to-late life somatic health conditions

DOI: 10.1038/s41398-022-01919-9

Year: 2022

Comorbidity of atopic diseases and gastroesophageal reflux- evidence of a shared cause.

DOI: 10.1111/cea.14106

Year: 2022

Correction: The role of ADHD genetic risk in mid-to-late life somatic health conditions

DOI: 10.1038/s41398-022-01933-x

Year: 2022

Acute COVID-19 severity and mental health morbidity trajectories in patient populations of six nations: an observational study

DOI: 10.1016/S2468-2667(22)00042-1

Year: 2022

TU5. PHENOME-WIDE ASSOCIATION STUDY BETWEEN ADHD POLYGENIC RISK AND ELECTRONIC HEALTH RECORD ICD-10 DIAGNOSIS CODES IN THE ESTONIAN BIOBANK

DOI: 10.1016/j.euroneuro.2021.08.009

Year: 2021

TU34. ASSOCIATION BETWEEN DEPRESSION DIAGNOSIS, POLYGENIC RISK FOR DEPRESSION AND ANTIHYPERTENSIVE MEDICATION NON-PERSISTENCE

DOI: 10.1016/j.euroneuro.2021.08.037

Year: 2021

W57. MENTAL HEALTH DATA COLLECTION IN THE ESTONIAN BIOBANK: INSTRUMENTS, METHODOLOGY AND PRELIMINARY RESULTS

DOI: 10.1016/j.euroneuro.2021.08.142

Year: 2021

Editorial: Genetics of Age-Related Diseases and Their Risk and Protective Factors

DOI: 10.3389/fgene.2021.771109

Year: 2021

1057Addressing challenges in life-course epidemiology: established and novel approaches using big data and twin/family studies

DOI: 10.1093/ije/dyab168.459

Year: 2021

Cohort Profile: COVIDMENT: COVID-19 cohorts on mental health across six nations

DOI: 10.1093/ije/dyab234

Year: 2021

What Is the Impact of Demographic Transition on Epidemiology?

What Measures Can Schools Implement to Prevent Disease Spread?

What Education and Training are Needed?

What is Differential Privacy?

How is Geographical Spread Monitored?

How is K-Anonymity Achieved?

How Does the FDA Ensure Drug Safety?

What Constitutes a Disability?

What Are Risks and Benefits?

What is International Aid?

Partnered Content Networks

Relevant Topics